ArticleNPJ precision oncology2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.
Christoph Arolt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it